Pharma Mar SA (PHMMF)
Conference Call to Discuss Jazz Pharmaceuticals License Agreement for Lurbinectedin in the U.S.
January 9, 2020 8:00 AM ET
Company Participants
José Luis Moreno – Director of Investor Relations & Capital Markets
Pascal Besman – U.S. Chief Operating Officer
Luis Mora – Managing Director-Oncology
Conference Call Participants
Jason Gerberry – Bank of America
Christian Glennie – Stifel
Esther Rajavelu – Oppenheimer
Samir Devani – Rx Securities
Presentation
Operator
Greetings. Welcome to the PharmaMar Conference Call in relation to License Agreement for Lurbinectedin signed between PharmaMar and Jazz Pharmaceuticals. At this time,